Hitting the hidden: arming the immune system for the next zoonotic coronavirus spillover
Journal of Clinical Investigation · 16.03.2026 · 136 (6)
DOI: 10.1172/jci203781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.03.2026. Verfasst von Charlie Fricke und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Vaccines, Pandemics. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Coronaviruses, both known and yet to emerge, pose persistent zoonotic and pandemic threats. While current parenteral COVID-19 mRNA vaccines effectively mitigate severe disease caused by SARS-CoV-2, they primarily elicit systemic immunity restricted to specific variants within clade 1b of the sarbecovirus subgenus and provide limited mucosal protection. Addressing these shortcomings, Cheang et al. developed a DC-targeting intranasal booster vaccine that induces robust and durable mucosal and systemic immunity across sarbecovirus clades 1a and 1b. This study highlights a promising strategy for pan-sarbecovirus vaccines by leveraging mucosal immune induction to prevent viral transmission and enhance pandemic preparedness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- NIAID NIH HHS
Zitieren
APA
Fricke, C., & Perlman, S. (2026). Hitting the hidden: arming the immune system for the next zoonotic coronavirus spillover. Journal of Clinical Investigation, 136(6). https://doi.org/10.1172/jci203781
Vancouver
Fricke C, Perlman S. Hitting the hidden: arming the immune system for the next zoonotic coronavirus spillover. Journal of Clinical Investigation. 2026;136(6). doi:10.1172/jci203781
BibTeX
@article{Fricke2026,
author = {Fricke, Charlie and Perlman, Stanley},
title = {Hitting the hidden: arming the immune system for the next zoonotic coronavirus spillover},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {6},
doi = {10.1172/jci203781}
}
EUVIMED